Franklin Resources
AGRX

Franklin Resources’s Agile Therapeutics AGRX Stock Holding History

Franklin Resources’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-306
Closed -$302K – 1554
2018
Q2 		$302K Sell
306
-1,372
-82% -$4.81M ﹤0.01% 1391
2018
Q1 		$8.62M Buy
1,678
+244
+17% +$1.61M ﹤0.01% 948
2017
Q4 		$7.71M Buy
1,434
+48
+3% +$447K ﹤0.01% 995
2017
Q3 		$12.4M Hold
1,386
– – 0.01% 902
2017
Q2 		$10.4M Buy
1,386
+390
+39% +$2.7M 0.01% 938
2017
Q1 		$6.38M Buy
996
+317
+47% +$1.59M ﹤0.01% 1062
2016
Q4 		$7.74M Sell
679
-21
-3% -$294K ﹤0.01% 1019
2016
Q3 		$9.77M Hold
700
– – 0.01% 982
2016
Q2 		$10.7M Hold
700
– – 0.01% 955
2016
Q1 		$8.69M Buy
+700
New +$9.04M ﹤0.01% 1011

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return